The use of intravenous intermediate dose melphalan and dexamethasone as induction treatment in the management of de novo multiple myeloma
Author:
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1998.tb01093.x/fullpdf
Reference21 articles.
1. Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimens;Alexanian;JAMA,1969
2. Chemotherapy of previously untreated myeloma patients: an analysis of recent treatment results;Sporn;Semin Oncol,1980
3. Comparison of MP with VBMCP for the treatment of multiple myeloma. Results of Eastern Cooperative Oncology Group Study E2479;Oken;Cancer,1997
4. Results of the MRC myelomatosis trials for patients entered since 1980;Maclennan;Haematol Oncol,1988
5. Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis;Maclennan;Lancet,1992
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Guidelines on the management of AL amyloidosis;British Journal of Haematology;2014-10-10
2. A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis;British Journal of Haematology;2012-03-06
3. Amyloidosis;Postgraduate Haematology;2010-11-16
4. Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma;British Journal of Haematology;2009-03
5. Guidelines on the diagnosis and management of AL amyloidosis;British Journal of Haematology;2004-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3